Abstract:BACKGROUND: Vascular endothelial growth factor (VEGF) induces bone marrow-derived mesenchymal stem cell (BMSC) differentiation into vascular endothelial-like cells and promotes BMSC migration toward gliomas. However, the molecular mechanisms by which VEGF induces BMSC differentiation and migration remain poorly understood.OBJECTIVE: To investigate the role of platelet-derived growth factor (PDGF) receptor (PDGFR) in BMSC differentiation and migration induced by VEGF.DESIGN, TIME AND SETTING: A parallel, controlled, in vitro experiment was performed at the Molecular Neurobiology & Neural Regeneration and Repairing Laboratory, Anhui Provincial Hospital of Anhui Medical University, China from June 2008 to March 2009.MATERIALS: U87 glioma cells were purchased from Shanghai Institutes for Biological Sciences; mouse anti-human PDGFR and VEGF receptor (VEGFR) monoclonal antibodies were purchased from Peprotech, USA.METHODS: Isolated BMSCs were precultured with neutralizing antibody for VEGFR-1, VEGFR-2, PDGFR-alpha, and PDGFR-beta to block biological activity of related receptors, followed by induced differentiation with 50 mu g/L VEGF. BMSCs induced with 50 mu g/L VEGF alone served as the VEGF-induced group. The control group remained untreated.MAIN OUTCOME MEASURES: Cell surface markers were identified by flow cytometry; BMSC surface cytokine receptor expression was detected by reverse transcription-polymerase chain reaction; the Transwell model was used to observe cell migration.RESULTS: After blocking the PDGFR, VEGF did not induce BMSC cell surface marker CD-31 or von Willebrand factor (vWF) expression. However, inhibition with VEGF receptor blocking agents, VEGF induced BMSCs to express CD-31 and vWF. Following inhibition of the PDGFR, the number of cells migrating through the polycarbonate membrane Transwell chamber was decreased, as well as the number of BMSCs migrating to glioma cells. However, through the use of VEGF receptor blocking agents, the number of migrating cells remained unchanged. VEGF preculture increased the number of BMSCs migrating to gliomas.CONCLUSION: VEGF interacts with PDGFRs on the BMSC surface to attract BMSC directional migration and induce BMSC differentiation. The VEGF/PDGFR pathway participates in BMSC directional migration to glioma. VEGF pretreatment increased efficiency of BMSC migration to glioma.

Participation of PI3K and ERK1/2 Pathways Are Required for Human Brain Vascular Smooth Muscle Cell Migration

Intracellular Signal Transduction for Migration and Actin Remodeling in Vascular Smooth Muscle Cells after Sphingosylphosphorylcholine Stimulation.

Autocrine VEGF and IL-8 Promote Migration Via Src/Vav2/Rac1/PAK1 Signaling in Human Umbilical Vein Endothelial Cells

Autocrine VEGF and IL-8 Promote Migration via Src/Vav2/Rac1/PAK1 Signaling in Human Umbilical Vein Endothelial Cells.

Signaling Pathways of Smooth Muscle Cell Migration when Phosphorylaion of Myosin Light Chain Was Inhibited

Role of Ras/PKCζ/MEK/ERK1/2 Signaling Pathway in Angiotensin II-induced Vascular Smooth Muscle Cell Proliferation

VEGF165 Modulates Proliferation, Adhesion, Migration and Differentiation of Cultured Human Outer Root Sheath Cells from Central Hair Follicle Epithelium Through VEGFR-2 Activation in Vitro

Interleukin-6 triggers human cerebral smooth muscle cell proliferation

Impact of ERK2 signaling pathway blockade on platelet-derived growth factor-induced vascular smooth muscle cells proliferation,migration and transform growth factar-β1 expression

MAP Kinases, Phosphatidylinositol 3-Kinase, and P70 S6 Kinase Mediate the Mitogenic Response of Human Endothelial Cells to Vascular Endothelial Growth Factor.

Impact of Insulin-like Growth Factor-I on Migration, Proliferation and Akt-ERK Signaling in Early and Late-passages of Vascular Smooth Muscle Cells

Vascular Endothelial Growth Factor/platelet-Derived Growth Factor Receptor Pathway is Involved in Bone Marrow Mesenchymal Stem Cell Differentiation and Directional Migration Toward Gliomas

Brain Derived Neurotrophic Factor Induces Endothelial Cells Angiogenesis Through AKT and ERK1/2 Signal Pathway.

SIRT1 Mediates Sphk1/S1P-induced Proliferation and Migration of Endothelial Cells.

Vascular endothelial growth factor-C promotes human mesenchymal stem cell migration via an ERK-and FAK-dependent mechanism

Vascular Endothelial Growth Factor A/Vascular Endothelial Growth Factor Receptor 2 Axis Promotes Human Dental Pulp Stem Cell Migration Via The Fak/Pi3k/Akt And P38 Mapk Signalling Pathways

Interleukin-6 Triggers Human Cerebral Endothelial Cells Proliferation and Migration: the Role for KDR and MMP-9.

Abstract 705: Epha2 Ligand-dependent And Ligand-independent Signaling In Vascular Smooth Muscle Cell Proliferation And Migration

Involvement of Akt1/protein Kinase Bα in Tumor Conditioned Medium-Induced Endothelial Cell Migration and Survival in Vitro

Pathogenesis of cardiovascular disease: Regulation of extracellular signal-regulated kinase on angiotensin II-induced proliferation of vascular smooth muscle cells

Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells.